ENTRY       D03914                      Drug
NAME        Dronedarone hydrochloride (USP);
            Multaq (TN)
PRODUCT     MULTAQ (Cardinal Health 107)
            MULTAQ (sanofi-aventis U.S. LLC)
FORMULA     C31H44N2O5S. HCl
EXACT_MASS  592.2738
MOL_WEIGHT  593.2174
CLASS       Cardiovascular agent
             DG01575  Calcium channel blocker
              DG01496  Calcium channel L type blocker
             DG01456  Adrenergic receptor agonist
             DG01653  Antiarrhythmics
              DG01648  Class III antiarrhythmic agent
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
            Metabolizing enzyme inhibitor
             DG01645  CYP2D6 inhibitor
             DG02852  CYP3A/CYP3A4 inhibitor
            Transporter inhibitor
             DG01622  ABCB1 inhibitor
REMARK      ATC code: C01BD07
            Chemical structure group: DG00207
            Product (DG00207): D03914<US>
EFFICACY    Antiarrhythmic
COMMENT     Amiodarone derivative
TARGET      CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]
            KCND3 [HSA:3752] [KO:K04893]
            KCNH2 [HSA:3757] [KO:K04905]
            KCNQ1 [HSA:3784] [KO:K04926]
            KCNJ3 [HSA:3760] [KO:K04997]
            KCNJ5 [HSA:3762] [KO:K04999]
            KCNJ11 [HSA:3767] [KO:K05004]
            ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]
            ADRB1 [HSA:153] [KO:K04141]
  PATHWAY   hsa04010(775+776+778+779)  MAPK signaling pathway
            hsa04020(146+147+148+153+775+776+778+779)  Calcium signaling pathway
            hsa04260(775+776+778+779)  Cardiac muscle contraction
            hsa04261(146+147+148+153+3784+775+776+778+779)  Adrenergic signaling in cardiomyocytes
            hsa04270(146+147+148+775+776+778+779)  Vascular smooth muscle contraction
METABOLISM  Enzyme: CYP3A [HSA:1576 1577 1551]
INTERACTION CYP inhibition: CYP3A [HSA:1576 1577 1551], CYP2D6 [HSA:1565]
            Transporter inhibition: ABCB1 [HSA:5243]
STR_MAP     map07037  Antiarrhythmic drugs
            map07231  Sodium channel blocking drugs
            map07232  Potassium channel blocking and opening drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01B ANTIARRHYTHMICS, CLASS I AND III
                C01BD Antiarrhythmics, class III
                 C01BD07 Dronedarone
                  D03914  Dronedarone hydrochloride (USP) &lt;US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Antiarrhythmics
               Vaughn Williams-Class III
                Dronedarone
                 D03914  Dronedarone hydrochloride (USP)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01575  Calcium channel blocker
               DG01496  Calcium channel L type blocker
                DG00207  Dronedarone
                 D03914  Dronedarone hydrochloride
              DG01456  Adrenergic receptor agonist
               DG00207  Dronedarone
                D03914  Dronedarone hydrochloride
              DG01653  Antiarrhythmics
               DG01648  Class III antiarrhythmic agent
                DG00207  Dronedarone
                 D03914  Dronedarone hydrochloride
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG00207  Dronedarone
                D03914  Dronedarone hydrochloride
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG00207  Dronedarone
                D03914  Dronedarone hydrochloride
              DG02852  CYP3A/CYP3A4 inhibitor
               DG00207  Dronedarone
                D03914  Dronedarone hydrochloride
             Transporter inhibitor
              DG01622  ABCB1 inhibitor
               DG00207  Dronedarone
                D03914  Dronedarone hydrochloride
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG01653  Antiarrhythmics
               D03914  Dronedarone hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA1
                 D03914  Dronedarone hydrochloride (USP) &lt;US&gt;
                ADRB1
                 D03914  Dronedarone hydrochloride (USP) &lt;US&gt;
             Ion channels
              Voltage-gated ion channels
               Calcium channels
                CACNA1-L
                 D03914  Dronedarone hydrochloride (USP) &lt;US&gt;
               Potassium channels
                KCND3
                 D03914  Dronedarone hydrochloride (USP) &lt;US&gt;
                KCNH2
                 D03914  Dronedarone hydrochloride (USP) &lt;US&gt;
                KCNQ1
                 D03914  Dronedarone hydrochloride (USP) &lt;US&gt;
               Inward rectifier channels (Kir)
                KCNJ3
                 D03914  Dronedarone hydrochloride (USP) &lt;US&gt;
                KCNJ5
                 D03914  Dronedarone hydrochloride (USP) &lt;US&gt;
                KCNJ11
                 D03914  Dronedarone hydrochloride (USP) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D03914
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03914
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D03914
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D03914
             Drug transporters
              D03914
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01575  Calcium channel blocker
               DG01496  Calcium channel L type blocker
                DG00207  Dronedarone
              DG01456  Adrenergic receptor agonist
               DG00207  Dronedarone
              DG01653  Antiarrhythmics
               DG01648  Class III antiarrhythmic agent
                DG00207  Dronedarone
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG00207  Dronedarone
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG00207  Dronedarone
              DG02852  CYP3A/CYP3A4 inhibitor
               DG00207  Dronedarone
             Transporter inhibitor
              DG01622  ABCB1 inhibitor
               DG00207  Dronedarone
DBLINKS     CAS: 141625-93-6
            PubChem: 17397988
            LigandBox: D03914
ATOM        40
            1   C8y C    22.8367  -17.7635
            2   C8x C    22.8367  -19.1718
            3   C8x C    24.0563  -19.8760
            4   C8y C    25.2760  -19.1718
            5   C8y C    25.2760  -17.7635
            6   C8x C    24.0563  -17.0594
            7   O2x O    26.6154  -19.6070
            8   C8y C    27.4432  -18.4677
            9   C8y C    26.6154  -17.3284
            10  N1b N    21.6172  -17.0594
            11  S4a S    20.4146  -17.7539
            12  C1a C    19.1949  -18.4580
            13  O3c O    21.1296  -18.9929
            14  O3c O    19.7219  -16.5537
            15  C5a C    26.6154  -15.9201
            16  C8y C    27.8471  -15.2087
            17  O5a O    25.4191  -15.2294
            18  C1b C    28.8220  -18.4677
            19  C8x C    29.0672  -15.9128
            20  C8x C    30.2867  -15.2085
            21  C8y C    30.2863  -13.8002
            22  C8x C    29.0664  -13.0960
            23  C8x C    27.8468  -13.8004
            24  O2a O    31.5077  -13.0947
            25  C1b C    32.7291  -13.7996
            26  C1b C    33.9139  -13.1152
            27  C1b C    35.1174  -13.8099
            28  N1c N    36.3111  -13.1205
            29  C1b C    37.5100  -13.8127
            30  C1b C    38.7060  -13.1219
            31  C1b C    29.5262  -17.2481
            32  C1b C    30.9343  -17.2481
            33  C1a C    31.6289  -16.0454
            34  C1b C    36.3110  -11.7080
            35  C1b C    37.5118  -11.0146
            36  C1b C    38.7052  -11.7034
            37  C1a C    39.9039  -11.0110
            38  C1b C    39.9037  -13.8134
            39  C1a C    41.1003  -13.1223
            40  X   Cl   36.3300  -18.7600
BOND        41
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 2
            10    5   9 1
            11    1  10 1
            12   10  11 1
            13   11  12 1
            14   11  13 2
            15   11  14 2
            16    9  15 1
            17   15  16 1
            18   15  17 2
            19    8  18 1
            20   16  19 2
            21   19  20 1
            22   20  21 2
            23   21  22 1
            24   22  23 2
            25   16  23 1
            26   21  24 1
            27   24  25 1
            28   25  26 1
            29   26  27 1
            30   27  28 1
            31   28  29 1
            32   29  30 1
            33   18  31 1
            34   31  32 1
            35   32  33 1
            36   28  34 1
            37   34  35 1
            38   35  36 1
            39   36  37 1
            40   30  38 1
            41   38  39 1
///
